These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 20617405)

  • 1. Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results.
    Khan KA; Ahmad A; Marini C; Nicotra M; Di Cerbo A; Fazal-Ur-Rehman ; Ullah N; Khan GM
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion-exchange resins as drug delivery carriers.
    Guo X; Chang RK; Hussain MA
    J Pharm Sci; 2009 Nov; 98(11):3886-902. PubMed ID: 19226637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between the effect of strongly and weakly cationic exchange resins on matrix physical properties and the controlled release of diphenhydramine hydrochloride from matrices.
    Akkaramongkolporn P; Wongsermsin K; Opanasopit P; Ngawhirunpat T
    AAPS PharmSciTech; 2010 Sep; 11(3):1104-14. PubMed ID: 20617405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ion exchange resins on the drug release from matrix tablets.
    Sriwongjanya M; Bodmeier R
    Eur J Pharm Biopharm; 1998 Nov; 46(3):321-7. PubMed ID: 9885305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro release of dual-drug resinates containing equivalent content dextromethorphan and diphenhydramine.
    Akkaramongkolporn P; Kulvanich P; Pathipvanich M
    Drug Dev Ind Pharm; 2006 Apr; 32(4):483-96. PubMed ID: 16638687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.
    Siepmann J; Kranz H; Bodmeier R; Peppas NA
    Pharm Res; 1999 Nov; 16(11):1748-56. PubMed ID: 10571282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of bi-layer matrix tablets of tramadol hydrochloride: Comparison of rate retarding ability of the incorporated hydrophilic polymers.
    Arif H; Al-Masum A; Sharmin F; Reza S; Sm Islam SA
    Pak J Pharm Sci; 2015 May; 28(3):855-61. PubMed ID: 26004717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a pharmaceutical cationic exchange resin on the properties of controlled release diphenhydramine hydrochloride matrices using Methocel K4M or Ethocel 7cP as matrix formers.
    Akkaramongkolporn P; Ngawhirunpat T; Nunthanid J; Opanasopit P
    AAPS PharmSciTech; 2008; 9(3):899-908. PubMed ID: 18668370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A; Kotwal V
    AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release and diffusional modeling of metronidazole lipid matrices.
    Ozyazici M; Gökçe EH; Ertan G
    Eur J Pharm Biopharm; 2006 Jul; 63(3):331-9. PubMed ID: 16621486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionality comparison of 3 classes of superdisintegrants in promoting aspirin tablet disintegration and dissolution.
    Zhao N; Augsburger LL
    AAPS PharmSciTech; 2005 Dec; 6(4):E634-40. PubMed ID: 16408865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of excipients on drug release from hydroxypropyl methylcellulose matrices.
    Levina M; Rajabi-Siahboomi AR
    J Pharm Sci; 2004 Nov; 93(11):2746-54. PubMed ID: 15389670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices--influence of agitation rate and dissolution medium composition.
    Kavanagh N; Corrigan OI
    Int J Pharm; 2004 Jul; 279(1-2):141-52. PubMed ID: 15234802
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.